Condition: Fragile X Syndrome · Sponsor: Mirum Pharmaceuticals, Inc.
This study is a multicenter, double-blind, randomized, placebo-controlled study to assess the safety and tolerability of 3 doses of MRM-3379 in male participants with Fragile X Syndrome ages 16 to 45 (inclusive). In addition, a parallel cohort of participants ages 13 to \<16 will receive open-label MRM-3379. All participants will participate for 12 weeks of treatment. The study is also intended as a proof-of-concept investigation to evaluate whether MRM-3379 can improve FXS symptoms
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Southwest Autism Research & Resource Center | Phoenix, Arizona, United States | Recruiting |
| Amnova Clinical Research, LLC | Irvine, California, United States | Recruiting |
| Children's Hospital of Orange County - Pediatric Subspecialty | Orange, California, United States | Not Yet Recruiting |
| Uc Davis Mind Institute | Sacramento, California, United States | Recruiting |
| Children's Hospital Colorado | Aurora, Colorado, United States | Recruiting |
| Neurology | Miami, Florida, United States | Not Yet Recruiting |
| Emory University - The Emory Clinic - Clifton Road | Atlanta, Georgia, United States | Recruiting |
| Rush University Medical Center-Clinical Operation | Chicago, Illinois, United States | Recruiting |
| Kennedy Krieger Institute, John Hopkins School of Medicine | Baltimore, Maryland, United States | Recruiting |
| Boston Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| UMass Memorial Health | Worcester, Massachusetts, United States | Recruiting |
| University of Minnesota Department of Medicine | Minneapolis, Minnesota, United States | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07209462